The announced March 31, 2026 Reverse Morris Trust transaction to combine McCormick with Unilever Foods (excluding India) at a $44.8 billion enterprise value drives current sentiment, creating a scaled global flavor leader with roughly $20 billion in combined FY2025 revenue. Unilever shareholders would receive 55.1% of the combined equity plus $15.7 billion cash, while McCormick shareholders retain 35%, with closing targeted for mid-2027 pending shareholder and regulatory approvals. July 2026 updates on the post-deal operating model, four commercial divisions, and planned London secondary listing signal execution progress, though UK CMA scrutiny and potential antitrust reviews remain key hurdles. Trader focus centers on approval timelines, integration risks, and any shifts in valuation multiples around 13.8x EBITDA.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertWill McCormick merge with Unilever Foods by...?
December 31, 2026
23%
June 30, 2027
49%
December 31, 2027
53%
$606 Vol.
December 31, 2026
23%
June 30, 2027
49%
December 31, 2027
53%
This market will resolve to "Yes" if the merger between McCormick & Company and Unilever Foods is completed by the specified date, 11:59 PM ET. Otherwise, this market will resolve to "No".
The merger will be considered completed once it has become legally effective and the two companies are now a single entity or they exist under a single entity as one corporate group, as evidenced by official company announcements and/or regulatory filings (e.g. the filing of an 8-K form to the SEC that announces the closure of the deal). Shareholder approval, receipt of regulatory approvals, regulatory filings which do not announce the closure of the deal, or other intermediate steps towards the closing of a deal will not alone be sufficient for a ‘Yes’ resolution.
If the merger agreement is officially terminated or the deal has been abandoned according to official company communications, this market will resolve to “No”.
Resolution will be based on official company communications and regulatory filings from McCormick & Company, Unilever, or a combined successor entity, supplemented as needed by a consensus of reporting from major reputable news outlets.
Markt eröffnet: May 20, 2026, 11:49 AM ET
Resolver
0x65070BE91...This market will resolve to "Yes" if the merger between McCormick & Company and Unilever Foods is completed by the specified date, 11:59 PM ET. Otherwise, this market will resolve to "No".
The merger will be considered completed once it has become legally effective and the two companies are now a single entity or they exist under a single entity as one corporate group, as evidenced by official company announcements and/or regulatory filings (e.g. the filing of an 8-K form to the SEC that announces the closure of the deal). Shareholder approval, receipt of regulatory approvals, regulatory filings which do not announce the closure of the deal, or other intermediate steps towards the closing of a deal will not alone be sufficient for a ‘Yes’ resolution.
If the merger agreement is officially terminated or the deal has been abandoned according to official company communications, this market will resolve to “No”.
Resolution will be based on official company communications and regulatory filings from McCormick & Company, Unilever, or a combined successor entity, supplemented as needed by a consensus of reporting from major reputable news outlets.
Resolver
0x65070BE91...The announced March 31, 2026 Reverse Morris Trust transaction to combine McCormick with Unilever Foods (excluding India) at a $44.8 billion enterprise value drives current sentiment, creating a scaled global flavor leader with roughly $20 billion in combined FY2025 revenue. Unilever shareholders would receive 55.1% of the combined equity plus $15.7 billion cash, while McCormick shareholders retain 35%, with closing targeted for mid-2027 pending shareholder and regulatory approvals. July 2026 updates on the post-deal operating model, four commercial divisions, and planned London secondary listing signal execution progress, though UK CMA scrutiny and potential antitrust reviews remain key hurdles. Trader focus centers on approval timelines, integration risks, and any shifts in valuation multiples around 13.8x EBITDA.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert



Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen